DIO Corporation (KOSDAQ:039840)
14,100
-70 (-0.49%)
Jun 2, 2026, 3:30 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 189.16 billion as of June 3, 2026. Its market cap has decreased by -31.67% in one year.
Market Cap
189.16B
Enterprise Value
228.23B
Revenue
169.60B
Ranking
n/a
PE Ratio
23.63
Stock Price
14,100.00
Market Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 189.16B, an increase of 644.11%. That is a compound annual growth rate of 8.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 189.16B | -16.35% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.74T |
| Celltrion | 40.18T |
| ALTEOGEN | 19.58T |
| Samsung Epis Holdings | 12.01T |
| Chong Kun Dang Holdings | 206.85B |
| REYON Pharmaceutical | 187.08B |
| Hyundai Pharmaceutical | 186.55B |
| Whan In Pharm | 186.32B |